Back
Pliant Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
20
PLRX
Pliant Therapeutics
Last Price:
$1.46
Seasonality Move:
-12.6%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.36 | Buy |
| 20-day SMA: | 1.4 | Buy |
| 50-day SMA: | 2.63 | Sell |
| 200-day SMA: | 10.29 | Sell |
| 8-day EMA: | 1.4 | Buy |
| 20-day EMA: | 1.55 | Sell |
| 50-day EMA: | 3.32 | Sell |
| 200-day EMA: | 9.06 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 37.19 | Sell |
| Chaikin Money Flow: | 26685 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.58) | Buy |
| Bollinger Bands (100): | (2.24 - 13.28) | Sell |
Pliant Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.46 while PLRX 8-day simple moving average is 1.36, which is a Buy signal.
-
The stock price of PLRX is 1.46 while Pliant Therapeutics 20-day SMA is 1.40, which makes it a Buy.
-
Pliant Therapeutics 50-day simple moving average is 2.63 while PLRX share price is 1.46, making it a Sell technically.
-
PLRX stock price is 1.46 and Pliant Therapeutics 200-day simple moving average is 10.29, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
20
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a SellThe current Pliant Therapeutics [PLRX] share price is $1.46. The Score for PLRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
89.4M
Price in USD:
1.46
Share Volume:
758.2K
Pliant Therapeutics 52-Week Range
52-Week High:
16.52
52-Week Low:
1.10
Sell
20
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?The Pliant Therapeutics stock price is 1.46 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.46 while PLRX 8-day exponential moving average is 1.40, which is a Buy signal.
-
The stock price of PLRX is 1.46 while Pliant Therapeutics 20-day EMA is 1.55, which makes it a Sell.
-
Pliant Therapeutics 50-day exponential moving average is 3.32 while PLRX share price is 1.46, making it a Sell technically.
-
PLRX stock price is 1.46 and Pliant Therapeutics 200-day simple moving average is 9.06, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.19 per share, an increase this year of $1.27 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is -0.39, suggesting Pliant Therapeutics is a Sell
-
Pliant Therapeutics Relative Strength Index (RSI) is 37.19, which suggest Pliant Therapeutics is oversold
-
The Bollinger Bands (25) for Pliant Therapeutics is (1.32 - 1.58), which suggest Pliant Therapeutics is a Sell
-
The Bollinger Bands (100) for Pliant Therapeutics is (2.24 - 13.28), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.